Evidence map›Paper›PMID 24456160›Full record

ArticleJournal of the American Chemical Society2014

Acceleration of an aromatic Claisen rearrangement via a designed spiroligozyme catalyst that mimics the ketosteroid isomerase catalytic dyad.

Matthew F L Parker, Sílvia Osuna, Guillaume Bollot, Shivaiah Vaddypally, Michael J Zdilla, K N Houk, Christian E Schafmeister

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Metal Cation-Binding Mechanisms of Q-Proline Peptoid Macrocycles in Solution.Journal of chemical information and modeling · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew F L ParkerDepartment of Chemistry, Temple University , 1901 North 13th Street, Philadelphia, Pennsylvania, 19122, United States.
Sílvia Osuna
Guillaume Bollot
Shivaiah Vaddypally
Michael J Zdilla
K N Houk
Christian E Schafmeister

Funding

STEREOSELECTIVITIES OF SYNTHETIC ORGANIC REACTIONSR01GM036700 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 1986 to 2013
$2.4M
Synthesis and Applications of functional MacromoleculesR01GM067866 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHAFMEISTER, CHRISTIAN E · 2004 to 2014
$2.4M
STEREOSELECTIVITIES OF SYNTHETIC ORGANIC REACTIONSR37GM036700 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 1997 to 2005
$1.5M
NIGMS NIH HHS GM067866NIGMS NIH HHS GM-36700
6 · The paper itself

Abstract

A series of hydrogen-bonding catalysts have been designed for the aromatic Claisen rearrangement of a 1,1-dimethylallyl coumarin. These catalysts were designed as mimics of the two-point hydrogen-bonding interaction present in ketosteroid isomerase that has been proposed to stabilize a developing negative charge on the ether oxygen in the migration of the double bond.1 Two hydrogen bond donating groups, a phenol alcohol and a carboxylic acid, were grafted onto a conformationally restrained spirocyclic scaffold, and together they enhance the rate of the Claisen rearrangement by a factor of 58 over the background reaction. Theoretical calculations correctly predict the most active catalyst and suggest that both preorganization and favorable interactions with the transition state of the reaction are responsible for the observed rate enhancement.

Indexed as

Biomimetic MaterialsCatalysisCoumarinsHydrogen BondingMethylationModels, MolecularSteroid IsomerasesCoumarinsSteroid Isomerases

Identifiers

PMID24456160
PMCPMC4004270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.